| A Study to Evaluate the Safety, Tolerability, PK and Efficacy of Hemay5087 in Patients With Advanced Solid Tumors (NCT07624864) | Ganzhou Hemay Pharmaceutical Co., Ltd | 2026-07-15 |
| Hemay005 for the Treatment of Chinese Moderately to Severely Active Ulcerative Colitis (NCT07650942) | Ganzhou Hemay Pharmaceutical Co., Ltd | 2026-06-01 |
| A Study to Investigate the Biomarkers of Hemay005 in Adult Participants With Moderate to Severe COPD (NCT07314242) | Ganzhou Hemay Pharmaceutical Co., Ltd | 2026-01-01 |
| A Clinical Study Evaluating the Preliminary Anti-tumor Efficacy and Safety of Hemay181 (NCT07446816) | Ganzhou Hemay Pharmaceutical Co., Ltd | 2025-12-03 |
| Pharmacokinetic Interactions Between Hemay005 Tablets and Midazolam Maleate Tablets (NCT06610890) | Ganzhou Hemay Pharmaceutical Co., Ltd | 2024-12-12 |
| Bioequivalence Test of Hemay005 Tablets (NCT06610903) | Ganzhou Hemay Pharmaceutical Co., Ltd | 2024-09-15 |
| To Evaluate the Pharmacokinetics of Hemay005 Tablets in Patients With Renal Impairment (NCT06380153) | Ganzhou Hemay Pharmaceutical Co., Ltd | 2024-05-07 |
| To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage (NCT06376474) | Ganzhou Hemay Pharmaceutical Co., Ltd | 2024-04-28 |
| A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease (NCT06145893) | Ganzhou Hemay Pharmaceutical Co., Ltd | 2023-11-13 |
| A Phase I Study of Hemay181 in Patients With Advanced Solid Tumors (NCT05749432) | Ganzhou Hemay Pharmaceutical Co., Ltd | 2023-03-20 |
| A Study of Hemay005 in Adult With Atopic Dermatitis (NCT05769946) | Ganzhou Hemay Pharmaceutical Co., Ltd | 2022-11-24 |
| Phase II Study of Hemay005 in Patients With Active Ulcerative Colitis (NCT05486104) | Ganzhou Hemay Pharmaceutical Co., Ltd | 2022-11-08 |
| In Vivo Mass Balance Study of [14C]Hemay005 (NCT05468645) | Ganzhou Hemay Pharmaceutical Co., Ltd | 2022-07-25 |